Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: MagnaPhos
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
MagnaPhos 97.2mg (4mmol) capsules
0905013G0BGACA4
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 346 |
|
MagnaPhos 97.2mg (4mmol) chewable tablets
0905013G0BGABDE
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 259 |
|
MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution
0905013G0BGADDF
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 94 |
|
MagnaPhos 48.6mg (2mmol) capsules
0905013G0BGAABM
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 90 |
|
MagnaPhos 97.2mg/5ml (4mmol/5ml) oral solution
0905013G0BGAEDC
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 37 |
|
MagnaPhos 39.5mg (1.6mmol) capsules
0905013G0BGAFDB
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.